Boosting immune system a potential treatment strategy for COVID-19
New research from Washington University School of Medicine suggests that the immune systems of seriously ill COVID-19 patients can’t do enough to protect them from the virus. The researchers propose that boosting the activity of immune cells may be a good treatment strategy for COVID-19.
COVID-19 vaccine trials to be conducted at Washington University, Saint Louis University
Researchers at Washington University School of Medicine and the Saint Louis University Center for Vaccine Development have joined the effort to find a COVID-19 vaccine that can prevent the illness. Researchers at the universities expect to enroll about 3,000 participants in several COVID-19 vaccine trials.
Lab-made virus mimics COVID-19 virus
To help efforts to find drugs and vaccines for COVID-19, researchers at Washington University School of Medicine developed a hybrid virus that will enable more scientists to enter the fight against the pandemic. The researchers genetically modified a mild virus.
Gut bacteria protect against mosquito-borne viral illness
A new study from Washington University School of Medicine has found that mice infected with Chikungunya virus get less sick and are less likely to transmit the virus to mosquitoes if they have healthy gut microbiomes.
Global wildlife surveillance could provide early warning for next pandemic
A team of wildlife biologists and infectious disease experts, including some at the School of Medicine, propose in an article published in Science a decentralized, global wildlife biosurveillance system to identify animal viruses that have the potential to cause human disease – before the next pandemic emerges.
Search for cure for common parasitic infection focus of $5.5 million NIH grant
Parasitologist L. David Sibley at the School of Medicine is leading an international effort to find drugs to cure toxoplasmosis, a parasitic disease characterized by vision problems and brain complications.
Experimental drug shows early promise against inherited form of ALS, trial indicates
An experimental drug for a rare, inherited form of amyotrophic lateral sclerosis (ALS) has shown promise in a phase 1/phase 2 clinical trial conducted at Washington University School of Medicine and other sites.
Effort to screen potential COVID-19 antiviral drugs underway
The School of Medicine’s Jennifer A. Philips, MD, PhD, has set up a screening platform to test compounds for activity against the COVID-19 virus. Her lab has screened dozens of compounds and is prepared to accept more suggestions of promising candidate molecules.
COVID-19 antibody tests evaluated as diagnostic test in low-resource settings
Faculty at the Washington University School of Medicine have joined an international effort led by the Foundation for Innovative New Diagnostics and the World Health Organization (WHO) to evaluate COVID-19 antibody tests for use as diagnostics in places with limited resources.
Oral antibiotics work, shorten hospital stays for IV drug users with infections
A combination of IV and oral antibiotics can effectively treat invasive infections in people who inject illicit drugs, according to a study from Washington University School of Medicine. The findings mean that patients can leave the hospital and complete taking their prescribed antibiotics at home.
Older Stories